Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Focus ; 12(9): 1-4, 1997 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-11364626

RESUMEN

AIDS: The issues of HIV resistance and its relation to patient adherence to treatment are discussed. Non-compliance or misuse of combination therapy fears are usually directed at a single group, substance abusers. There are differences in the availability and use of HIV treatment by race, gender, and injection drug use status. Those most affected by injection-drug-related HIV disease, and thus from treatment, are Hispanics and African-Americans. Complying with HIV drug treatment regimens can be difficult but it is important since non-adherence to drug therapy, once started, can develop a new strain of HIV that may be resistant to a particular antiviral drug. Unfortunately, twelve years of studies have found non-adherence to be the norm in general medical treatment. Many reasons exist, including the patient's decision to non-comply. Researchers have found that while short-term adherence can be increased with some simple actions, long-term compliance is more difficult and labor intensive. To help long-term compliance, practitioners must understand their patients' belief systems, deliver accurate information to influence beliefs, and in cases when competing demands are compelling, help to reduce distractions. For injection drug users, withdrawal is the chief distraction, and addressing that distraction is a primary negative influence on adherence. Since research cannot identify who will or will not adhere, it is suggested that generic judgments be avoided and HIV treatment be available to all in need.^ieng


Asunto(s)
Fármacos Anti-VIH/uso terapéutico , Farmacorresistencia Microbiana , Infecciones por VIH/tratamiento farmacológico , Cooperación del Paciente , Negro o Afroamericano , Conducta , Infecciones por VIH/psicología , Hispánicos o Latinos , Humanos , Relaciones Médico-Paciente , Abuso de Sustancias por Vía Intravenosa
2.
Pediatr Clin North Am ; 42(2): 431-51, 1995 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-7724268

RESUMEN

Ethnic and cultural diversity are important determinants of alcohol and drug use patterns and consequences. Cultural differences constitute proximal determinants of alcoholism and imply certain differences in attitudes, values, and perceptual constructs as a result of different culturally based experiences. Thus, all children and adolescents are not equal clinically; transcultural communication is necessary for effective identification, diagnosis, and management of substance use disorders. Health status antecedents to, and consequences of, substance use disorders in ethnic groups of color are examined. Drinking is explored in biological, cultural, and social contexts.


Asunto(s)
Características Culturales , Etnicidad , Trastornos Relacionados con Sustancias/etnología , Adolescente , Niño , Femenino , Estado de Salud , Humanos , Masculino , Grupos Raciales , Factores de Riesgo , Trastornos Relacionados con Sustancias/diagnóstico , Trastornos Relacionados con Sustancias/terapia , Estados Unidos/epidemiología
3.
Recent Dev Alcohol ; 12: 387-407, 1995.
Artículo en Inglés | MEDLINE | ID: mdl-7624554

RESUMEN

The initial focus is on defining race, culture, and ethnicity, followed by a review of the extent of alcohol and alcohol use consequences among African-Americans and Native Americans. Cultural specificity in an historical context is provided. A brief overview of gaps in the incident and prevalence data is presented. The biosociocultural context of drinking among African-American women with specific emphasis on cultural disruption, socialization, and social class is explored. A triracial infant girl (African-American/Native American/German-Irish-American), whose family genogram documents, by the case study method, six generations back to slavery, is presented. The alcohol use patterns within this family are somewhat illustrative of historical patterns and of racial and ethnic import. An absence of religiosity/spirituality is noted. The family genogram is followed by a discussion of the limitations of the case study method of family genograms. The final section relates the findings of the family genogram back to the extant data and the gaps in the collection of data regarding the epidemiology of alcoholism across groups. It highlights the recent findings and questions raised by those findings from cross-cultural and racial studies of alcoholism among women of color.


Asunto(s)
Alcoholismo/genética , Negro o Afroamericano/psicología , Comparación Transcultural , Indígenas Norteamericanos/genética , Población Blanca/psicología , Aculturación , Adolescente , Adulto , Negro o Afroamericano/estadística & datos numéricos , Anciano , Alcoholismo/etnología , Alcoholismo/psicología , Niño , Hijo de Padres Discapacitados/psicología , Preescolar , Estudios Transversales , Femenino , Genotipo , Humanos , Incidencia , Indígenas Norteamericanos/psicología , Indígenas Norteamericanos/estadística & datos numéricos , Lactante , Recién Nacido , Masculino , Persona de Mediana Edad , Desarrollo de la Personalidad , Factores de Riesgo , Caracteres Sexuales , Medio Social , Estados Unidos , Población Blanca/estadística & datos numéricos
4.
J Psychoactive Drugs ; 27(1): 39-47, 1995.
Artículo en Inglés | MEDLINE | ID: mdl-7602439

RESUMEN

This article describes a 300-bed substance abuse treatment program that is part of a continuum of care focused on preventing drug and criminal recidivism in substance abusing criminals incarcerated in Dallas County, Texas. It is the product of a joint effort of the judiciary, the Dallas County Supervision and Corrections Department, the State of Texas Criminal Justice Division, and Interventions Co., a not-for-profit treatment provider. The program is rooted in over 25 years of treatment experience and incorporates therapeutic community (TC) technology combined with 12-Step programming, behavior modification, job training (having a job is required for graduation), educational, and medical/psychiatric elements. Treatment is conceived as part of a continuum of care to provide substantial and sustained support for the inmate in the difficult process of adapting to the community post incarceration. Treatment plans are individualized and are based on an extended workup in which the individual's status in a number of domains is assessed. Specialized services, such as transportation and childcare, facilitate recovery. Once in the community, urine monitoring, groups, and counseling continue. The program is beginning its fourth year of operation and approximately 600 inmates have started the program. A formal evaluation is in process.


Asunto(s)
Tratamiento Domiciliario , Trastornos Relacionados con Sustancias/rehabilitación , Adulto , Crimen , Etnicidad , Familia , Femenino , Humanos , Masculino , Recurrencia , Apoyo Social , Trastornos Relacionados con Sustancias/psicología , Texas , Comunidad Terapéutica
5.
J Addict Dis ; 13(3): 65-9, 1994.
Artículo en Inglés | MEDLINE | ID: mdl-7734460

RESUMEN

In a pilot study, 130 methadone maintained subjects with a six-month history of good treatment performance were assigned randomly, for a one-year study period, to an experimental condition (once per month non-random urine screen, counseling session and doctor visit, two times per month methadone pick up, a quarterly true random urine screen, and participation in a diversion control program), or they were assigned to a control condition of staying under standard conditions for six months and then being transferred to the experimental condition for six months. Three out of four subjects (73%) completed the year in good standing with no differences between control and experimental conditions. Subject satisfaction was such that the Institutional Review Board judged that return to standard conditions would be a hardship. A Study of Medical Maintenance (SMM) continues and extends the pilot study with two protocols: (1) for new subjects and (2) for subjects entered from the pilot study. SMM requires a once per month random urine screen and extends the experimental condition to two years but is otherwise identical to the pilot study; 71 of 107 S's (66%) entered protocol 1 and are in good standing. Pilot subjects (N = 75) are holding their good performance, some for over four years. The reduced levels of services in these studies free up resources which can be applied to entering IDU's into treatment thereby contributing to a slowing of the HIV epidemic.


Asunto(s)
Metadona/uso terapéutico , Trastornos Relacionados con Opioides/rehabilitación , Grupo de Atención al Paciente , Abuso de Sustancias por Vía Intravenosa/rehabilitación , Adulto , Terapia Conductista , Terapia Combinada , Consejo , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Trastornos Relacionados con Opioides/psicología , Cooperación del Paciente/psicología , Proyectos Piloto , Rehabilitación Vocacional/psicología , Detección de Abuso de Sustancias , Abuso de Sustancias por Vía Intravenosa/psicología , Resultado del Tratamiento
6.
J Addict Dis ; 12(4): 59-76, 1993.
Artículo en Inglés | MEDLINE | ID: mdl-8292640

RESUMEN

In a one year study, 130 methadone maintained subjects with a six month history of good treatment performance were assigned randomly to an experimental condition of one monthly non-random urine screen, one monthly counseling session, one monthly doctor visit, two times per month methadone pick up, a quarterly true random urine screen and participation in a diversion control program or to a control condition of staying under standard conditions for six months and then being transferred to the experimental condition for six months. Results of urine screens and scores on the Addiction Severity Index (ASI) at entrance and six month intervals showed no differences between groups. Three out of four subjects completed the year in good standing. Subject satisfaction was such that the IRB judged that return to standard conditions would be a hardship. Experimental conditions were cheaper such that resources freed up could be applied to the HIV epidemic.


Asunto(s)
Metadona/uso terapéutico , Trastornos Relacionados con Sustancias/tratamiento farmacológico , Adulto , Femenino , Seropositividad para VIH/complicaciones , Seropositividad para VIH/diagnóstico , Humanos , Masculino , Metadona/administración & dosificación , Metadona/orina , Persona de Mediana Edad , Proyectos Piloto , Índice de Severidad de la Enfermedad , Trastornos Relacionados con Sustancias/complicaciones , Trastornos Relacionados con Sustancias/prevención & control , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA